Atlas Trials

Intranasal Dexmedetomidine and Zolpidem for Treatment of Primary Insomnia

Clinical trial NCT05615727 · UNKNOWN

Trial details

NCT number
NCT05615727
Sponsor
The University of Hong Kong
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Insomnia
Start date
2022-09-01
Primary completion
2023-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.